DRC Ebola Outbreak Surpasses 1,150 Cases Amidst Rapid Spread
The Democratic Republic of Congo (DRC) has reported a significant increase in confirmed Ebola cases, reaching 1,155 with 304 deaths, according to government data as of June 24, 2026. This rapidly escalating outbreak, caused by the virulent Bundibugyo strain, has prompted the World Health Organization to declare it a Public Health Emergency of International Concern.
Key Highlights
- DRC confirmed 1,155 Ebola cases and 304 deaths as of June 24, 2026.
- Outbreak, caused by Bundibugyo strain, declared a global health emergency.
- Cases are primarily in Ituri, North Kivu, and South Kivu provinces.
- Virus has spread to Uganda with 20 cases and one case imported to France.
- Response hindered by conflict, displacement, and lack of Bundibugyo vaccine.
- Children face higher fatality rates, with 3 million children at risk.
The Democratic Republic of Congo (DRC) is currently grappling with a severe and rapidly escalating Ebola outbreak, with government data revealing 1,155 confirmed cases and 304 deaths as of June 24, 2026. This alarming surge represents a significant increase, with 37 new cases and five new deaths reported in the 24 hours prior to the data compilation. Health officials attribute the rising numbers to intensified epidemiological and biological surveillance, which has enabled earlier case detection, while also confirming a continuous week-on-week growth in community transmission.
The current outbreak, the 17th recorded in the DRC since 1976, was officially declared on May 15, 2026, in the Ituri Province. Just days later, on May 16 or 17, 2026, the World Health Organization (WHO) elevated the crisis to a Public Health Emergency of International Concern (PHEIC), signifying the outbreak's serious nature and its potential for international spread. The WHO Director-General underscored that this designation requires coordinated global efforts to contain the virus.
One of the most critical aspects distinguishing this outbreak is that it is caused by the Bundibugyo virus (BDBV) species, rather than the more commonly known Zaire ebolavirus. This presents a significant challenge for response efforts, as existing approved vaccines and specific treatments are not effective against the Bundibugyo strain. Medical experts are candid about the knowledge gaps concerning this specific variant, which is complicating detection and care. The early symptoms of Bundibugyo Ebola are often mild and resemble other common diseases like malaria, leading to delays in seeking care and further transmission.
The outbreak's epicenter remains Ituri Province, which accounts for the vast majority of confirmed cases (over 90%). However, cases have also been reported in neighboring North Kivu and South Kivu provinces. The virus has demonstrated cross-border transmission, with Uganda reporting 20 confirmed cases and two deaths as of June 24/25, 2026, primarily linked to individuals who traveled from the affected regions in the DRC. Additionally, international spread has been confirmed with one imported case reported in France on June 24, 2026, and another in Germany on May 19, 2026, involving a US citizen who was medically evacuated.
The response to this outbreak is severely hampered by a complex interplay of factors, including persistent insecurity, armed conflict, and population displacement in eastern DRC. These conditions create significant access restrictions for health workers and humanitarian agencies, making surveillance, contact tracing, and safe burial practices extremely difficult. Misinformation and community distrust further complicate efforts, with instances of health workers being attacked and patients fleeing isolation facilities. The presence of artisanal mining sites also contributes to high population mobility, facilitating the virus's spread.
This 2026 Ebola outbreak has been characterized by an unprecedented speed of transmission, with cases rising faster than in any previous Ebola outbreak in history. By June 22, 2026, it had already become the second-largest Ebola outbreak on record. The humanitarian impact is profound, particularly on children. UNICEF has warned that approximately 3 million children and adolescents are vulnerable, not only to the disease itself but also to the disruption of essential social services. Children represent around 15% of confirmed cases but alarmingly account for over 25% of confirmed deaths, indicating a higher fatality rate among the youngest population. The long-term implications for families, health systems, and regional stability are considerable, underscoring the critical need for sustained international support and intervention.
Frequently Asked Questions
What is the current status of the Ebola outbreak in the Democratic Republic of Congo?
As of June 24, 2026, the Democratic Republic of Congo has reported 1,155 confirmed Ebola cases and 304 deaths. The outbreak is rapidly escalating, with a continuous increase in community transmission.
Which type of Ebola virus is causing this outbreak, and is there a vaccine?
This outbreak is caused by the Bundibugyo virus (BDBV). Unlike the Zaire strain, there is currently no approved vaccine or specific treatment available for the Bundibugyo virus, complicating containment efforts.
How has the outbreak spread geographically?
The outbreak is concentrated in the Ituri Province of the DRC, with cases also in North Kivu and South Kivu. It has spread to neighboring Uganda (20 confirmed cases) and there have been imported cases reported in France and Germany.
What are the main challenges in responding to this Ebola outbreak?
Response efforts are severely hindered by ongoing armed conflict, insecurity, and population displacement, which limit access for health workers. Additionally, misinformation and community distrust pose significant challenges, along with the absence of a vaccine for the Bundibugyo strain.
Why is this outbreak considered a Public Health Emergency of International Concern (PHEIC)?
The World Health Organization declared this a PHEIC due to the rapid and unprecedented spread of the Bundibugyo virus, the high number of cases, the lack of an effective vaccine or treatment for this strain, and the potential for international spread, necessitating a coordinated global response.